simbiology matlab (MathWorks Inc)
97
Structured Review
MathWorks Inc
simbiology matlab

Simbiology Matlab, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 97/100, based on 621 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/matlab+software+programming+language/SimBiology/pmc05845055-320-41-43
Average 97 stars, based on 621 article reviews

Simbiology Matlab, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 97/100, based on 621 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/matlab+software+programming+language/SimBiology/pmc05845055-320-41-43
Average 97 stars, based on 621 article reviews
simbiology matlab - by Bioz Stars,
2026-11
97/100 stars
Images
1) Product Images from "gPKPDSim: a SimBiology ® -based GUI application for PKPD modeling in drug development"
Article Title: gPKPDSim: a SimBiology ® -based GUI application for PKPD modeling in drug development
Journal: Journal of Pharmacokinetics and Pharmacodynamics
doi: 10.1007/s10928-017-9562-9
Figure Legend Snippet: A schematic workflow of how modelers and end-users employ gPKPDSim. The expert modeler develops the model in SimBiology ® and encapsulates it into a “Session” file, which can be launched in gPKPDSim by end-users. The Session file, once loaded in gPKPDSim, enables the end-user to perform different functionalities, including simulation, data fitting (parameter estimation), population simulation, and NCA. For some of these functionalities, the user must provide a dataset. All the functionalities are supported by features such as interactive visualization, and export of results as presentation-ready figures and Excel datasets. When the user completed their tasks, the session file can be saved for future use. Note that the end-user works exclusively in the environment of gPKPDSim
Techniques Used:
Figure Legend Snippet: Description of the components within the gPKPDSim framework
Techniques Used: Generated
Figure Legend Snippet: gPKPDSim: simulation functionality view. This view has multiple sections: 1 ) general settings (top left); 2 ) functionality-specific settings including simulation time and parameter values (bottom left); 3 ) plot settings including species from the SimBiology ® model and dataset groups and column headers (top right); 4 ) non-compartmental analysis (NCA, bottom right); 5 ) profile notes including a list of most recent simulations and their detailed summary (bottom middle); and 6 ) interactive plots (top middle). See “ ” for detailed description of each section
Techniques Used:
Figure Legend Snippet: A summary of different settings in gPKPDSim
Techniques Used: Selection, Variant Assay
Related Articles
other:Article Title: Reaction-kinetic model-driven dual-enzyme catalyzed system for highly efficient synthesis of glutathione Article Snippet: Glutathione (GSH) is an important bioactive tripeptide with widespread applications in food additives, pharmaceutical, and cosmetics.. In this study, an efficient one-pot enzymatic system for GSH synthesis was established by coupling bifunctional glutathione synthetase (GshF) with polyphosphate kinase (PPK).. A dual-enzyme reaction-kinetic model was constructed using condition-dependent apparent kinetic parameters to providing predictive parameters of the cascade enzyme reaction. Article Title: Sub-stoichiometric degradation is dispensable for potent PROTACs as demonstrated by irreversible covalent BTK degraders. Article Snippet: Article Title: Inhalation exposure and uptake modeling of particle-associated phthalate: from respiratory deposition and clearance to organ toxicokinetics. Article Snippet: This study aimed to develop a novel hybrid computational fluid-particle dynamics (CFPD)–physiologically-based pharmacokinetics (PBPK) model to elucidate the toxicokinetics of particle-associated di(2-Ethylhexyl) phthalate (DEHP) in the human body via inhalation exposure.. Initially, a steady mucus flow was simulated with constant rates for the upper and lower respiratory tracts.. The desorption, dynamics, and tissue absorption of DEHP were simultaneously described by the Eulerian approach and the mucus–tissue–blood model. Mucociliary clearance effects were examined against the DEHP and its particle carriers using the steady rate constant. Software:Article Title: A multiscale quantitative systems pharmacology platform for early screening of MMAE-based antibody-drug conjugates. Article Snippet: .. Model development and simulations were performed using Platinum:Article Title: Integrating a Tumor Size-Overall Survival Model Into a Spatial Quantitative Systems Pharmacology Framework for Antibody-Drug Conjugates in Non-Small Cell Lung Cancer. Article Snippet: .. The model was implemented in Clinical Proteomics:Article Title: Development of isourea-based covalent GPX4 inhibitors and structure–activity relationship analysis in ferroptosis induction Article Snippet: .. Pharmacokinetic parameters, including systemic clearance, steady-state volume of distribution, terminal half-life, maximum plasma concentration, time to maximum plasma concentration, area under the plasma concentration–time curve to the last measurable time point, and oral bioavailability, were calculated by Concentration Assay:Article Title: Development of isourea-based covalent GPX4 inhibitors and structure–activity relationship analysis in ferroptosis induction Article Snippet: .. Pharmacokinetic parameters, including systemic clearance, steady-state volume of distribution, terminal half-life, maximum plasma concentration, time to maximum plasma concentration, area under the plasma concentration–time curve to the last measurable time point, and oral bioavailability, were calculated by Analysis:Article Title: Development of isourea-based covalent GPX4 inhibitors and structure–activity relationship analysis in ferroptosis induction Article Snippet: .. Pharmacokinetic parameters, including systemic clearance, steady-state volume of distribution, terminal half-life, maximum plasma concentration, time to maximum plasma concentration, area under the plasma concentration–time curve to the last measurable time point, and oral bioavailability, were calculated by |